Skip to main content
Boston Scientific’s family of CRT devices


Our focus

We strive to be a world class leader in minimally invasive devices for diagnosing and treating gastrointestinal and airway conditions.

See our work in action

By combining a relentless dedication to developing an evolving portfolio of less-invasive technologies with a spirit of collaboration with healthcare professionals, we’re committed to improving patient care through continuous innovation, product development excellence and world-class support within the gastrointestinal, pancreaticobiliary, surgical and airway spaces.

Delivering meaningful innovation

Supporting infection prevention.

The EXALT™ Model D Single-Use Duodenoscope is the first single-use duodenoscope, enabling physicians to complete endoscopic retrograde cholangiopancreatography (ERCP) procedures to diagnose and treat various pancreatic and biliary conditions. EXALT Model D was developed as an alternative to reusable duodenoscopes, eliminating the need for reprocessing and repairs, and allowing physicians to use a new, sterile device for every procedure.

Addressing outcomes.  

The SpyGlass™ DS Direct Visualization System, a single-use, single-operator digital cholangioscope, enables physicians to see high-resolution images from inside the biliary, hepatic and pancreatic ducts during ERCP. When used with the SpyBite™ Max Biopsy Forceps, physicians are enabled to take targeted biopsies of strictures to diagnose diseases such as cholangiocarcinoma or pancreatic cancer. When used with EHL or laser lithotripsy, physicians have the tools to help them effectively and efficiently treat biliary stones.

Less-invasive treatment alternatives.

The AXIOS™ Stent and Electrocautery Enhanced Delivery System offers an endoscopic alternative for transgastric or transduodenal drainage of symptomatic pancreatic pseudocysts and certain types of walled-off necrosis - two serious complications of pancreatitis.

Offering services and solutions.

Boston Scientific offers a range of healthcare services and solutions that are designed to help clinicians in their efforts to maintain costs, improve operational efficiencies and deliver high-quality patient care. We offer a range of infection prevention products and solutions for use in the endoscopy suite. 

check icon

Since its launch in 2015, the SpyGlass™ Direct Visualization System has impacted nearly 300K patients across the globe.*

check icon

Worldwide, over 120K procedures have utilized the AXIOS™ Stent and Electrocautery Enhanced Delivery System.*

check icon

EXALT™ Model D is the only single-use duodenoscope with peer-reviewed, published data in 6 human clinical trials, involving more than 500 patients across all ERCP complexity grades.¹,²,³,⁴,⁵,⁶

Conditions our customers treat with Boston Scientific products

  • Malignant and Benign Tumors
  • Gastrointestinal Cancers & Diseases
  • Pancreaticobiliary Stones
  • Pulmonary Diseases & Lung Cancer
  • Airway & Breathing Conditions
  • Digestion & Nutrition
  • Upper and Lower GI bleeding
  • Pancreatitis


leading cause of cancer death in the U.S.: pancreatic.7


of all cancer-related deaths worldwide: gastrointestinal.8


mortality rate with upper GI bleeds.9

~3 million

antibiotic resistant infections each year in the U.S.10


cause of cancer death in the U.S.: pulmonary disease.7

Products and solutions we offer

  • Biliary Access
  • Biliary Stricture and Stone Management
  • Biopsy
  • Dilation
  • Endoscopic Ultrasound (EUS)
  • Hemostasis
  • Airway
  • Cholangioscopy
  • Stents: Enteral & Esophageal
  • Tissue Resection
  • Endoscopic Mucosal Resection
  • Enteral feeding
  • Radiofrequency ablation
  • Submucosal lifting agents
  • Infection prevention
  • Single-use imaging
  • Single-use scopes

Product spotlights

 *Data on file. 

  1. Bang et al. Equivalent performance of single-use and reusable duodenoscopes in a randomized trial. Gut 2020;0:1-7.
  2. Muthusamy et al. Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography. Clinical Gastroenterology and Hepatology 2020:1-10.
  3. Napolean et al. Evaluation of the performance of a single-use duodenoscope: Prospective multi-center national study, Digestive Endoscopy 2021:1-7.
  4. Slivka A et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021 Jun 26:S0016-5107(21)01464-4. doi: 10.1016/j.gie.2021.06.017. Epub ahead of print. PMID: 34186052.
  5. Shahid et al. Comparing the Safety and Efficacy of Two Commercially Available Single-Use Duodenoscopes. 2022 Aug 24. doi: 10.1097/MCG.0000000000001752. 
  6. D. Persyn et al. Performance and applicability of a first generation single-use duodenoscope: a single-center cohort study. Annals of Gastroenterology (2022) 35, 368-375.
  7. American Cancer Society. Cancer Facts & Figures 2021. Atlanta: American Cancer Society; 2021, Page 10
  8. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068. Epub 2020 Apr 2. PMID: 32247694
  9. Button, L.A., et al. Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. Alimentary Pharmacology & Therapeutics, 33: 64-76.
  10. CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019, Page 6
  11. As of July 2023.

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a physician.

Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.All trademarks are the property of their respective owners.